
Neonc Technologies Holdings
Clinical-stage life sciences company developing a novel intranasal drug delivery system for brain cancers and CNS diseases.
We may earn a commission from links on this Neonc Technologies Holdings profile. That does not change the facts we publish.
About
Neonc Technologies Holdings, Inc. is a life sciences company pioneering a new era in brain health by revolutionizing the treatment of Central Nervous System (CNS) diseases. They have developed a proprietary, patented platform technology designed to transport therapeutics directly to the brain, overcoming the limitations of the Blood-Brain Barrier.
Show 6 more similar companies
Similar companies
FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.
Shares MedTech, HealthTech
Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.
Shares Biotech, MedTech
Develops a brain-computer interface for treating epilepsy.
Shares MedTech, HealthTech
Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.
Shares MedTech, HealthTech
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotech, MedTech
AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment.
Shares MedTech, HealthTech
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Neonc Technologies Holdings?
People comparing tools land here. Get listed beside these.
Copy Neonc Technologies Holdings's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- neonc.com
- Employees
- 9
- Business model
- B2B
Neonc Technologies Holdings pricing

Plans as published by Neonc Technologies Holdings. Current prices on neonc.com
Tech stack
Detected on neonc.com, last scanned 18 Nov 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Video / media
- Vimeo
- Affiliate program
- Self-hosted affiliate
Benchmarking
See how your site ranks against 16,849 startups
Neonc Technologies Holdings sits in the 37th percentile for Domain Rating. Check where yours lands, free.
Neonc Technologies Holdings has a Domain Rating of 30, the 37th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Below median
Check yoursAgent Readiness
Above median
Scan yoursSite Speed
Bottom 25%
PageSpeedData Trust
Top 25%
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Neonc Technologies Holdings scores 41. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Neonc Technologies Holdings changes
Used Neonc Technologies Holdings? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Are there companies like Neonc Technologies Holdings?
Yes. We list 6 companies like Neonc Technologies Holdings, including FIZE Medical, Tortugas Neuroscience and NeuroPace.
What does Neonc Technologies Holdings do?
This technology aims to deliver more effective treatments for CNS diseases, including brain cancers, and is based on their proprietary synthesis of Perillyl Alcohol (POH).
Is Neonc Technologies Holdings trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Neonc Technologies Holdings is 79 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does Neonc Technologies Holdings have?
Neonc Technologies Holdings has approximately 9 people on record.
Does Neonc Technologies Holdings have an affiliate program?
Yes, Neonc Technologies Holdings has an affiliate program. The program runs on Self-hosted affiliate. Register here: neonc.com/affiliates
SEC filings, insider activity, nonprofit links and pay benchmarks for Neonc Technologies Holdings:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Neonc Technologies Holdings and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini



4 reviews from Reddit gathered in one place
The company is a clinical-stage biopharmaceutical business, developing treatments for brain cancers. It is offering 2.95M shares, expecting proceeds. The money will be used for general corporate purposes.
The company, formed in 2008, is a clinical-stage biopharmaceutical business developing treatments for brain cancers. It has two lead products: NEO100, delivered intranasally, and NEO212.
The President, a Director, and a 10% Owner, Amir F Heshmatpour, executed multiple open-market purchases totaling approximately $185,000, reinforcing his already substantial position in the company. Market Impact : This series of buys is a b…
NeOnc Technologies reported Q3 2025 results, highlighted operational updates including NEO100 Phase 2a data, FDA clearance for NEO212, and a $50M strategic partnership, with key milestones anticipated.
Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.